Carbocyclic 5′‐norcytidine (5′‐norcarbodine)

A preparation of (1′R,2′S,3′R,4′S)‐1‐(2′,3′,4′‐trihydroxycyclopent‐1′‐yl)‐lH‐cytosine (5′‐norcarbodine, 3 ) has formally been achieved in 2 steps from (+)‐(1R,4S)‐4‐hydroxy‐2‐cyclopenten‐1‐yl acetate ( 4 ) and cytosine. The L‐like enantiomer of 3 (that is, 6 ) is also reported using the enantiomer of 4 (that is, 7 ). In evalu ating 3 and 6 for antiviral potential against a number of viruses, compound 3 was found to have activity towards Epstein‐Barr virus (EBV).     

(Z)‐5‐[4‐(Dimethylamino)benzylidene]‐2‐(piperidin‐1‐yl)‐1,3‐thiazolidin‐4(5H)‐one

The molecules of the title compound, C₁₇H₂₁N₃OS, are characterized by a wide C—C—C angle at the methine C atom linking the aryl and thiazolidine rings, associated with a short repulsive intramolecular S...H contact between atoms in these two rings. A single piperidine–arene C—H...π hydrogen bond links pairs of molecules into centrosymmetric dimers.     

5‐(5‐Nitropyridin‐2‐yldithio)‐1‐phenyl‐1H‐tetrazole

In the title disulfide, C₁₂H₈N₆O₂S₂, all bond lengths and angles are within normal ranges, and the molecules are linked into centrosymmetric R₂²(20) dimers by simple C—H...N interactions. Weak intermolecular C—H...π(arene) and π–π interactions, involving the benzene CH groups and the benzene rings, and the pyridine rings, respectively, further stabilize and reinforce the crystal structure.     

η5‐(3)‐1‐Methyl‐1,2‐dicarbollyl‐η5‐2′,5′‐dimethylpyrrolylcobalt(III)

In the title compound, (η⁵‐2,5‐di­methyl­pyrrolyl)[(7,8,9,10,11‐η)‐7‐methyl‐7,8‐dicarba‐nido‐undecaborato]­cobalt(III), [3‐Co{η⁵‐[2,5‐(CH₃)₂‐NC₄H₂]}‐1‐CH₃‐1,2‐C₂B₉H₁₀] or [Co(C₃H₁₃B₉)(C₆H₈N)], the Co^III atom is sandwiched between the pentagonal faces of the pyrrolyl and dicarbollide ligands, resulting in a neutral mol­ecule. The C—C distance in the dicarbollide cage is 1.649 (3) Å.     

Syntheses of 1‐(4‐methylsulfonylphenyl)‐5‐aryl‐1,2,3‐triazoles and ‐(4‐aminosulfonylphenyl)‐5‐aryl‐1,2,3‐triazoles

Condensation of 4‐methylsulfonylaniline with aryl aldehyde in ethanol‐tetrahydrofuran afforded the imino compound 3 . 1,3‐Cycloaddtion of diazomethane with compound 3 followed by oxidazation of the triazoline 4 with potassium permanganate gave 1‐(4‐methylsulfonylphenyl)‐5‐aryl‐1,2,3‐triazoles 5 . Similarly, condensation of 4‐(N,N‐dibenzylaminosulfonyl)aniline with aryl aldehyde followed by 1,3‐cycloaddition of diazomethane with the imino compound 11 and the subsequent oxidation of triazoline 12 with potassium permanganate yielded the triazole 13 . Debenzylation of compound 13 with sulfuric acid gave the desired compound 1‐(4‐aminosulfonylphenyl)5‐aryl‐1,2,3‐triazoles 14 .     

Synthetic approaches to 4,8‐dimethyl‐5′‐(N‐pyridiniummethyl)‐ 4′,5′‐dihydropsoralens and 4,8‐dimethyl‐5′‐ (N‐aminomethyl)‐ 4′,5′‐dihydropsoralens

New synthetic approaches to 4,8‐dimethyl‐5′‐(N‐pyridiniummethyl)‐4′,5′‐dihydropsoralens and 4,8‐dimemyl‐5′‐(N‐aminomethyl)‐4′,5′‐dihydropsoralens are described. The 5′‐halomethyl‐4′,5′‐dihydro‐psoralen precursors are formed by electrophilic ring closures of 4,8‐dimethyl‐6‐allyl‐7‐hydroxycoumarin. The ring‐closure reactions may also be applied to the synthesis of 5′‐halomethyl‐4‐methyl‐4′,5′‐dihydroangelicins. The compounds are potential therapeutic agents for improved psoralen ultraviolet A radiation treatment.     

5‐Formylsalicylic acid and 5‐(benzimidazolium‐2‐yl)salicylate

Both title compounds are derivatives of salicylic acid. 5‐Formylsalicylic acid (systematic name: 5‐formyl‐2‐hydroxybenzoic acid), C₈H₆O₄, possesses three good hydrogen‐bond donors and/or acceptors coplanar with their attached benzene ring and abides very well by Etter's hydrogen‐bond rules. Intermolecular O—H...O and some weak C—H...O hydrogen bonds link the molecules into a planar sheet. Reaction of this acid and o‐phenylenediamine in refluxing ethanol produced in high yield the new zwitterionic compound 5‐(benzimidazolium‐2‐yl)salicylate [systematic name: 5‐(1H‐benzimidazol‐3‐ium‐2‐yl)‐2‐hydroxybenzoate], C₁₄H₁₀N₂O₃. Each imidazolium N—H group and its adjacent salicyl C—H group chelate one carboxylate O atom via hydrogen bonds, forming seven‐membered rings. As a result of steric hindrance, the planes of the molecules within these pairs of hydrogen‐bonded molecules are inclined to one another by ∼74°. There are also π–π stacking interactions between the parallel planes of the imidazole ring and the benzene ring of the salicyl component of the adjacent molecule on one side and the benzimidazolium component of the molecule on the other side.     

1,5‐Bis(4‐dithiocarboxylate‐5‐hydroxypyrazolyl)pentane derivatives of 5‐pyrazolones

3‐Methyl‐1‐phenyl‐2‐pyrazolin‐5‐one 1b and 1‐dodecyl‐3‐methyl‐2‐pyrazolin‐5‐one 1c react with carbon disulfide and 1,5‐dibromopentane in the presence of sodium acetate in dimethylfor‐mamide or n‐butyllithium in tetrahydrofuran to afford 1,5‐bis(4‐dithiocarboxylate‐5‐hydroy‐pyrazolyl)pentane derivatives 6b‐c.     

Synthesis of (5′S)‐5′‐C‐Alkyl‐2′‐deoxynucleosides

We describe the synthesis of (5′S)‐5′‐C‐butylthymidine ( 5a ), of the (5′S)‐5′‐C‐butyl‐ and the (5′S)‐5′‐C‐isopentyl derivatives 16a and 16b of 2′‐deoxy‐5‐methylcytidine, as well as of the corresponding cyanoethyl phosphoramidites 9a , b and 14a , b , respectively. Starting from thymidin‐5′‐al 1 , the alkyl chain at C(5′) is introduced via Wittig chemistry to selectively yield the (Z)‐olefin derivatives 3a and 3b (Scheme 2). The secondary OH function at C(5′) is then introduced by epoxidation followed by regioselective reduction of the epoxy derivatives 4a and 4b with diisobutylaluminium hydride. In the latter step, a kinetic resolution of the diastereoisomer mixture 4a and 4b occurs, yielding the alkylated nucleoside 2a and 2b , respectively, with (5′S)‐configuration in high diastereoisomer purity (de=94%). The corresponding 2′‐deoxy‐5‐methylcytidine derivatives are obtained from the protected 5′‐alkylated thymidine derivatives 7a and 7b via known base interconversion processes in excellent yields (Scheme 3). Application of the same strategy to the purine nucleoside 2′‐deoxyadenine to obtain 5′‐C‐butyl‐2′‐deoxyadenosine 25 proved to be difficult due to the sensitivity of the purine base to hydride‐based reducing agents (Scheme 4).     

Enzymatic Synthesis of Nucleoside‐5′‐O‐(1‐thiophosphates) and (SP)‐Adenosine‐5′‐O‐(1‐thiotriphosphate)

Treatment of adenosine with PSCl₃ in trimethyl phosphate gave, after ion‐exchange chromatography, adenosine‐5′‐O‐monophosphate (AMP; 28%) and adenosine‐5′‐O‐monothiophosphate (AMPS; 48%). AMPS was studied as a thiophosphate residue donor in an enzymatic transphosphorylation with nucleoside phosphotransferase (NPase) of the whole cells of Erwinia herbicola. As exemplified by a number of natural and sugar‐ and base‐modified nucleosides, it was demonstrated that NPase of the whole cells of Erwinia herbicola catalyzes the transfer of both thiophosphate and phosphate residues with a similar efficiency. An incubation of AMPS in a phosphorylating extract of Saccharomyces cerevisiae (K‐phosphate buffer (0.3 M , pH 7.0); 3% glucose; 15 mM MgCl₂; 28°, 8 h), followed by ion‐exchange column chromatography afforded AMP (8%), AMPS (recovered, 23%), ATP (11%), and (S_P)‐adenosine‐5′‐O‐(1‐thiotriphosphate) ((S_P)‐ATPαS); (total yield 37%; 48% based on the consumed AMPS). For comparison of physicochemical properties, adenosine was chemically transformed into ATPαS as a mixture of the (S_P) (53%) and (R_P) (44%) diastereoisomers.     

Synthesis of 3‐phenyl‐5‐(trifluoromethyl)isoxazole and 5‐phenyl‐3‐(trifluoromethyl)isoxazole

Reaction of 4,4,4‐trifluoro‐1‐phenyl‐1,3‐butanedione with hydroxylamine led to the formation of 5‐hydroxy‐3‐phenyl‐5‐(trifluoromethyl)‐4,5‐dihydroisoxazole which was dehydrated to 3‐phenyl‐5‐(trifluoro‐methyl)isoxazole. This isomer can also be synthesized by reaction of 4‐chloro‐4‐phenyl‐1,1,1‐trifluoro‐3‐buten‐2‐one with sodium azide. The regioisomer, 5‐phenyl‐3‐(trifluoromethyl)isoxazole was synthesized by reaction of 1,1,1‐trifluoro‐4‐phenylbut‐3‐yn‐2‐one with hydroxylamine and by the reaction of 3‐chloro‐1‐phenyl‐4,4,4‐trifluorobut‐2‐en‐1‐one with sodium azide. Both isomers were characterized by mass and NMR spectroscopy.     

Synthesis of novel 2‐(2‐methylsulfonyl‐1‐methyl‐1H‐imidazol‐5‐yl)‐5‐(alkylsulfonyl)‐1,3,4‐thiadiazoles

Starting from 5‐hydroxymethyl‐2‐mercapto‐1‐methyl‐1H‐imidazole (1), a series of 2‐(1‐methyl‐2‐methylsulfonyl‐1H‐imidazol‐5‐yl)‐5‐alkylthio and 5‐alkylsulfonyl‐1,3,4‐thiadiazole derivatives ( 9a , 9b , 9c , 9d and 10a , 10b , 10c , 10d ) were prepared as potential antimicrobial agents. The structure of the obtained compounds was confirmed by NMR, IR, Mass spectroscopy, and elemental analysis. J. Heterocyclic Chem., (2010)     

(5Z)‐4‐Amino‐2‐(4‐hydroxyphenyl)‐1H‐imidazol‐5(2H)‐one oxime 3‐oxide

The title molecule, C₉H₁₀N₄O₃, consists of benzene and imidazole rings which are almost perpendicular to each other. A hydroxyimino group is directly linked to the imidazole ring with a double C=N bond, which is the first example in this type of compound. The double bond may be a good location for the initiation of various reactions with a wide range of potential applications. In the crystal structure, there are π–π interactions between molecules related by a centre of symmetry, with the imidazole and benzene rings almost completely overlapped. The molecules are hydrogen bonded in each direction and form a three‐dimensional hydrogen‐bond network.     

(S)‐3‐(Ammoniomethyl)‐5‐methylhexanoate (pregabalin)

The title compound, C₈H₁₇NO₂, exists as a zwitterion, adopting a propeller conformation. Molecules self‐assemble to form a hydrogen‐bonded layer parallel to the ab crystallographic plane connected by N⁺—H...O⁻ and C—H...O⁻ hydrogen bonds. These layers are stacked along the c axis and are stabilized by van der Waals interactions.     

2‐Amino‐5‐(3,4‐dimethoxybenzylidene)‐1‐methylimidazol‐4(5H)‐one N,N‐dimethylformamide monosolvate

The crystal structure of the title compound, C₁₃H₁₅N₃O₃·C₃H₇NO, was determined as part of a larger project focusing on creatinine derivatives as potential pharmaceuticals. The molecule is essentially planar, in part because of intramolecular hydrogen bonding. Inversion‐related pairs of molecules result from intermolecular hydrogen bonding. The π systems of 2‐amino‐5‐(3,4‐dimethoxybenzylidene)‐1‐methylimidazol‐4(5H)‐one and an inversion‐related molecule overlap slightly, indicating a small amount of π–π stacking. Bond lengths, angles and torsion angles are consistent with similar structures, except in the imidazolone ring near the doubly bonded C atom, where significant differences occur.     

Poly[aquaneodymium(III)‐μ5‐2‐oxido‐5‐sulfonatobenzoato]

The title compound, [Nd(C₇H₃O₆S)(H₂O)]_n or [Nd(SSA)(H₂O)]_n (H₃SSA is 5‐sulfosalicylic acid), was synthesized by the hydrothermal reaction of Nd₂O₃ with H₃SSA in water. The compound forms a three‐dimensional network in which the asymmetric unit contains one Nd^III atom, one SSA ligand and one coordinated water mol­ecule. The central Nd^III ion is eight‐coordinate, bonded to seven O atoms from five different SSA ligands [Nd—O = 2.405 (4)–2.612 (4) Å] and one aqua O atom [Nd—OW = 2.441 (4) Å].     

Antibacterial and Antifungal Activities of 2‐(substituted ether)‐5‐(1‐phenyl‐5‐(trifluoromethyl)‐1H‐pyrazol‐4‐yl)‐1,3,4‐oxadiazole Derivatives

By replacing the amide bond into 1,3,4‐oxadiazole moiety, a series of 1‐phenyl‐5‐(trifluoromethyl)‐1H‐pyrazole derivatives bearing 1,3,4‐oxadiazole were synthesized and evaluated their antibacterial and antifungal activity. The bioassay results revealed that compounds 7a and 7b showed the strongest antibacterial activity toward pathogen Xanthomonas oryzae pv. oryzae with the EC50 values of 15.0 and 6.4 µg/mL, respectively; compound 6a exhibited comprehensive antifungal activity toward six kinds of fungi; compound 6f could selectively inhibit the growth of Sclertinia sclerotiorum and Rhizoctonia solani with the inhibition rates of 82.5 and 80.3% at the concentrate of 100 µg/mL, respectively; compound 7b exerted good antifungal activity toward Fusarium oxysporum, Cytospora mandshurica, and Rhizoctonia solani with the inhibition rates of 70.8, 69.5, and 71.5%, respectively. The results suggested that this kind of compounds could be further studied as promising antimicrobial agents.     

Diastereoselective synthesis of (2R,4S,5S)‐(+)‐5‐(2,2‐dichloroacetamido)‐ 4‐(4‐nitrophenyl)‐2‐aryl‐1,3‐dioxanes

(2R,4S,5S)‐(+)‐5‐(2,2‐Dichloroacetamido)‐4‐(4‐nitrophenyl)‐2‐aryl‐1,3‐dioxanes 3–8 were synthesized with high diastereoselectivity and good yields. The structures of acetals were determined and the configurations were confirmed by 2D‐NMR (NOESY) and X‐ray crystallographic analysis.     

In(OTf)3催化下水相合成2-(3,4,5-三甲氧基苯基)-5-[(5-烷硫基-1,3,4-噁二唑-2-基)硫甲基]-1,3,4-噻二唑类衍生物

以2-巯基-5-(3,4,5-三甲氧基苯基)-1,3,4-噻二唑为原料,经醚化、酰肼化、闭环、硫醚化四步反应合成了10个2-(3,4,5-三甲氧基苯基)-5-[(5-烷硫基-1,3,4-噁二唑-2-基)硫甲基]- 1,3,4-噻二唑类衍生物。通过元素分析、IR、MS、1H NMR和 13C NMR对目标化合物进行了表征。采用In(OTf)3催化下40 oC水相合成目标化合物,具有反应条件温和、合成收率高、催化剂可循环使用等特点。